Last reviewed · How we verify
NCT06916754
Comparing Combined Behavioral Intervention and Ericksonian Hypnotherapy for Alcohol Addiction
NA trial testing Combined Behavioral Intervention in Alcohol-Related Disorders in 90 participants. Currently enrolling.
15 November 2025
Quick facts
| Lead sponsor | Beykoz University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 90 |
| Start date | 1 March 2025 |
| Primary completion | 15 November 2025 |
| Estimated completion | 1 February 2026 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Combined Behavioral Intervention
- Ericksonian Hypnotherapy
Conditions studied
- Alcohol-Related Disorders — all drugs for Alcohol-Related Disorders →
- Alcoholism — all drugs for Alcoholism →
- Substance-related Disorders — all drugs for Substance-related Disorders →
Sponsor
Beykoz University
Who can join
Adults 18 to 65, any sex, with Alcohol-Related Disorders or Alcoholism. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This clinical study is being conducted to compare the effectiveness of two psychological treatments for alcohol addiction: Combined Behavioral Intervention (CBI) and Ericksonian Hypnotherapy (EH). The purpose of the study is to determine whether Ericksonian Hypnotherapy, a more personalized and indirect therapeutic method, is equal to or more effective than the gold-standard approach, Combined Behavioral Intervention, in helping individuals reduce their alcohol consumption and improve psychological well-being. Alcohol addiction is a serious condition that affects mental, emotional, and physical health. Many treatment options exist, but not all individuals respond in the same way. This study aims to evaluate two different types of therapy in a structured way, to better understand which works best, for whom, and under what circumstances. The study will include 90 adult participants diagnosed with Alcohol Use Disorder (AUD). Participants will be randomly assigned to one of three groups: (1) a group receiving weekly sessions of Combined Behavioral Intervention, (2) a group receiving weekly sessions of Ericksonian Hypnotherapy, or (3) a control group receiving general educational materials about alcohol addiction. Treatment will last for 12 weeks, and all participants will be followed up three months after the last session to assess long-term effects. Throughout the study, researchers will measure changes in alcohol consumption, alcohol craving, mental health symptoms (such as depression and anxiety), quality of life, and motivation to change. The findings of this study may help improve the way alcohol addiction is treated by offering evidence on alternative approaches such as hypnotherapy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06916754
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Alcohol-Related Disorders
Currently open trials in the same condition.
- NCT07039175 — Intervention to Increase Intention to Change Alcohol/Tobacco Use in Veterans With Chronic Disease · Phase 3 · recruiting
- NCT06070649 — The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD) · Phase 1 · recruiting
- NCT05910580 — Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years · NA · recruiting
- NCT07053098 — External Facilitation to Increase Prescribing of AUD Medications in the Psychiatric Setting · NA · recruiting
- NCT06729957 — Addressing Barriers to Care for Substance Use Disorder Trial · NA · active not recruiting
Other Beykoz University trials
Trials by the same sponsor.
- NCT07100951 — Comparing Brief Psychoanalytic Couple Therapy and Emotionally Focused Therapy in Reducing Relationship Distress · NA · recruiting
- NCT07040462 — Child-Parent Psychotherapy After the 2023 Kahramanmaraş Earthquake · NA · recruiting
- NCT06936397 — Cognitive Remediation Therapy for Schizophrenia: Effects on EEG and Emotional Regulation · NA · recruiting
- NCT06831708 — RCT of Short-Term Psychoanalytic vs. Cognitive Behavioral Therapy for GAD · NA · recruiting
- NCT06892613 — EFCT vs. BCT for Depression and Anxiety in Married Couples · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06916754 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Beykoz University
- Last refreshed: 16 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06916754.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing